Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
QuintilesIMS
Baxter
Medtronic
Cantor Fitzgerald
UBS
Farmers Insurance
Deloitte

Generated: June 18, 2018

DrugPatentWatch Database Preview

CITALOPRAM HYDROBROMIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Citalopram Hydrobromide, and when can generic versions of Citalopram Hydrobromide launch?

Citalopram Hydrobromide is a drug marketed by Mylan Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Lannett Co Inc, West-ward Pharms Int, Biovail Labs Intl, Actavis Elizabeth, Amneal Pharms Ny, Aurobindo, Chartwell Molecular, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, G And W Labs Inc, Glenmark Generics, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Pliva, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, Teva Pharms, Torpharm, Torrent Pharms, and Watson Labs. and is included in thirty-three NDAs.

The generic ingredient in CITALOPRAM HYDROBROMIDE is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
Drug patent expirations by year for CITALOPRAM HYDROBROMIDE
Pharmacology for CITALOPRAM HYDROBROMIDE
Medical Subject Heading (MeSH) Categories for CITALOPRAM HYDROBROMIDE
Synonyms for CITALOPRAM HYDROBROMIDE
(S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide
1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide
1-(3-(Dimethylamino)propyl)-1,-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide
1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide
1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIZOHYDRO-5-ISOBENZOFURANCARBONITRILE HYDROBROMIDE SALT
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile hydrobromide
4CH-017662
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,monohydrobromide
5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, HYDROBROMIDE (1:1)
59729-32-7
65822P
729C327
A832439
AB0107058
AB1010898
AB10921
AC-1595
AC1L2U9E
AK-72795
AKOS005145738
AN-14765
ANW-42935
Apertia
API0006328
ARK092
AX8121801
BC207875
BCP9000537
BG0143
Bio-0019
Bonitrile HBr
BR-72795
C 7861
C20H21FN2O.HBr
CCG-101022
CCG-213271
Celexa
Celexa (TN)
CHEMBL1200781
Cipramil
Citalopram (hydrobromide)
CITALOPRAM BROMOHYDRATE
Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard
Citalopram HBr
Citalopram hydrobromide (USAN)
Citalopram hydrobromide [USAN:USP]
Citalopram hydrobromide [USAN]
Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base)
Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base)
Citalopram hydrobromide, >=98% (HPLC)
Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard
Citalopram Hydrobromide, pharmaceutical secondary standard; traceable to USP, PhEur
Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard
CITALOPRAM, HYDROBROMIDE SALT
CPD000326936
CS-4735
CTK8B3679
D00822
DTXSID40872344
EINECS 261-890-6
Elopram
EU-0100258
FT-0600173
HSDB 7042
HY-B1287
I06-0616
J10477
KS-00000FXR
KS-1043
LP00258
LS-84329
Lu 10-171 HBr
Lu 10-171-B
LU-10-171 HYDROBROMIDE SALT
Lu-10-171B
LU-10171B
Lupram
MFCD02101306
MLS000758293
MLS000860078
MLS001401376
MLS002222294
MolPort-003-940-770
NC00272
NCGC00093717-01
NCGC00093717-02
NCGC00093717-03
NCGC00260943-01
Nitalapram HBr
NITALAPRAM HYDROBROMIDE SALT
NSC-758684
NSC758684
Pharmakon1600-01504172
Prepram HBr
Prisdal
Q-200865
recital hydrobromide
RP17855
s4749
SAM001246599
SAM001247086
SC-18021
SCHEMBL1118
Sepram
Seropram
SMR000326936
ST2403129
TL8003797
Tox21_500258
TR-020691
W-105304
WIHMBLDNRMIGDW-UHFFFAOYSA-N
Z1550648760
ZD-211

US Patents and Regulatory Information for CITALOPRAM HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077052-001 Jul 3, 2006 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
G And W Labs Inc CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077048-002 Nov 16, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Epic Pharma Llc CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077036-002 Oct 28, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077034-001 Jun 30, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Farmers Insurance
Daiichi Sankyo
Mallinckrodt
Johnson and Johnson
McKinsey
Moodys
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.